topiramate

Generic: topiramate

Labeler: remedyrepack inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name topiramate
Generic Name topiramate
Labeler remedyrepack inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

topiramate 100 mg/1

Manufacturer
REMEDYREPACK INC.

Identifiers & Regulatory

Product NDC 70518-1196
Product ID 70518-1196_48c0b1e2-203a-d7b2-e063-6394a90a1035
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076343
Listing Expiration 2027-12-31
Marketing Start 2018-05-15

Pharmacologic Class

Mechanism of Action
cytochrome p450 3a4 inducers [moa] cytochrome p450 2c19 inhibitors [moa]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 705181196
Hyphenated Format 70518-1196

Supplemental Identifiers

RxCUI
199889
UNII
0H73WJJ391
NUI
N0000008486 N0000185506 N0000182140

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name topiramate (source: ndc)
Generic Name topiramate (source: ndc)
Application Number ANDA076343 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 30 POUCH in 1 BOX (70518-1196-1) / 1 TABLET in 1 POUCH (70518-1196-2)
  • 30 TABLET in 1 BOTTLE, PLASTIC (70518-1196-5)
source: ndc

Packages (2)

70518-1196-1 30 POUCH in 1 BOX (70518-1196-1) / 1 TABLET in 1 POUCH (70518-1196-2) 70518-1196-5 30 TABLET in 1 BOTTLE, PLASTIC (70518-1196-5)

Ingredients (1)

topiramate (100 mg/1)

Linked Drug Pages (1)

Topiramate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48c0b1e2-203a-d7b2-e063-6394a90a1035", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199889"], "spl_set_id": ["44095c2b-2e90-45d2-ab45-d0961c41550d"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 BOX (70518-1196-1)  / 1 TABLET in 1 POUCH (70518-1196-2)", "package_ndc": "70518-1196-1", "marketing_start_date": "20191022"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (70518-1196-5)", "package_ndc": "70518-1196-5", "marketing_start_date": "20250513"}], "brand_name": "Topiramate", "product_id": "70518-1196_48c0b1e2-203a-d7b2-e063-6394a90a1035", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70518-1196", "generic_name": "Topiramate", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20180515", "listing_expiration_date": "20271231"}